|
1
|
Gish RG: Current treatment and future
directions in the management of chronic hepatitis B viral
infection. Clin Liver Dis. 9:541–565. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Ganem D and Varmus HE: The molecular
biology of the hepatitis B viruses. Annu Rev Biochem. 56:651–693.
1987. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Seeger C and Mason WS: Hepatitis B virus
biology. Microbiol Mol Biol Rev. 64:51–68. 2000. View Article : Google Scholar
|
|
4
|
Stemler M, Weimer T, Tu ZX, et al: Mapping
of B-cell epitopes of the human hepatitis B virus X protein. J
Virol. 64:2802–2809. 1990.PubMed/NCBI
|
|
5
|
Yeh CT, Shen CH, Tai DI, et al:
Identification and characterization of a prevalent hepatitis B
virus X protein mutant in Taiwanese patients with hepatocellular
carcinoma. Oncogene. 19:5213–5220. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Muroyama R, Kato N, Yoshida H, et al:
Nucleotide change of codon 38 in the X gene of hepatitis B virus
genotype C is associated with an increased risk of hepatocellular
carcinoma. J Hepatol. 45:805–812. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Tanaka Y, Kanai F, Ichimura T, et al: The
hepatitis B virus X protein enhances AP-1 activation through
interaction with Jab1. Oncogene. 25:633–642. 2006.PubMed/NCBI
|
|
8
|
Feng H, Tan TL, Niu D and Chen WN: HBV X
protein interacts with cytoskeletal signaling proteins through SH3
binding. Front Biosci (Elite Ed). 2:143–150. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Pang R, Lee TK, Poon RT, et al: Pin1
interacts with a specific serine-proline motif of hepatitis B virus
X-protein to enhance hepatocarcinogenesis. Gastroenterology.
132:1088–1103. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Doria M, Klein N, Lucito R and Schneider
RJ: The hepatitis B virus HBx protein is a dual specificity
cytoplasmic activator of Ras and nuclear activator of transcription
factors. EMBO J. 14:4747–4757. 1995.PubMed/NCBI
|
|
11
|
Qadri I, Conaway JW, Conaway RC, et al:
Hepatitis B virus transactivator protein, HBx, associates with the
components of TFIIH and stimulates the DNA helicase activity of
TFIIH. Proc Natl Acad Sci USA. 93:10578–10583. 1996. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Qadri I, Fatima K and Abdel-Hafiz H:
Hepatitis B virus X protein impedes the DNA repair via its
association with transcription factor, TFIIH. BMC Microbiol.
11:482011. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Loncarevic IF, Zentgraf H and Schröder CH:
Sequence of a replication competent hepatitis B virus genome with a
preX open reading frame. Nucleic Acids Res. 18:49401990. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Yang Q, Cheng J, Dong J, et al: Molecular
epidemiological study on pre-X region of hepatitis B virus and
identification of hepatocyte proteins interacting with whole-X
protein by yeast two-hybrid. World J Gastroenterol. 11:3473–3478.
2005. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Takahashi K, Kishimoto S, Ohori K, et al:
A unique set of mutations in the ‘preX’ region of hepatitis B virus
DNA frequently found in patients but not in asymptomatic carriers:
implication for a novel variant. Int Hepatol Commun. 3:131–138.
1995.
|
|
16
|
Lok AS, Akarca U and Greene S: Mutations
in the pre-core region of hepatitis B virus serve to enhance the
stability of the secondary structure of the pre-genome
encapsidation signal. Proc Natl Acad Sci USA. 91:4077–4081. 1994.
View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Buckwold VE, Xu Z, Yen TS and Ou JH:
Effects of a frequent double-nucleotide basal core promoter
mutation and its putative single-nucleotide precursor mutations on
hepatitis B virus gene expression and replication. J Gen Virol.
78:2055–2065. 1997.
|
|
18
|
Kurosaki M, Enomoto N, Asahina Y, et al:
Mutations in the core promoter region of hepatitis B virus in
patients with chronic hepatitis B. J Med Virol. 49:115–123. 1996.
View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Kidd-Ljunggren K, Oberg M and Kidd AH:
Hepatitis B virus X gene 1751 to 1764 mutations: implications for
HBeAg status and disease. J Gen Virol. 78:1469–1478.
1997.PubMed/NCBI
|
|
20
|
Zhou F, Mao Q, Lu Y, Chen M, Chen J, Wang
L, Ren J and Dong Z: Hepatitis B virus core promoter deletion
mutations can lead to the expression of HBeAg. Chinese Hepatology.
2008.228–230. 2008.(In Chinese).
|
|
21
|
Baha W, Ennaji MM, Lazar F, et al: HBV
genotypes prevalence, precore and basal core mutants in Morocco.
Infect Genet Evol. 12:1157–1162. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Locarnini S, McMillan J and Bartholomeusz
A: The hepatitis B virus and common mutants. Semin Liver Dis.
23:5–20. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Bouchard MJ and Schneider RJ: The
enigmatic X gene of hepatitis B virus. J Virol. 78:12725–12734.
2004. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Zoulim F, Saputelli J and Seeger C:
Woodchuck hepatitis virus X protein is required for viral infection
in vivo. J Virol. 68:2026–2030. 1994.PubMed/NCBI
|
|
25
|
Kumar V, Jayasuryan N and Kumar R: A
truncated mutant (residues 58-140) of the hepatitis B virus X
protein retains transactivation function. Proc Natl Acad Sci USA.
93:5647–5652. 1996. View Article : Google Scholar : PubMed/NCBI
|
